NeuroMetrix, Inc. Common Stock
NURO
NURO was delisted on the 1st of May, 2025.
8 hedge funds and large institutions have $700K invested in NeuroMetrix, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, reducing their positions, and 3 closing their positions.
36% more capital invested
Capital invested by funds: $515K → $700K (+$185K)
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$155K |
| 2 |
Renaissance Technologies
New York
|
+$90.1K |
| 3 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
+$76K |
| 4 |
VF
Virtu Financial
New York
|
+$39.2K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$20.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
-$58K |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$58K |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $310K | +$155K | +1,080 | +92% |
|
|
2
Renaissance Technologies
New York
| $214K | +$90.1K | +627 | +68% |
|
|
TDC
3
Thompson Davis & Co
Richmond,
Virginia
| $73K | +$76K | +529 | New |
|
|
VF
4
Virtu Financial
New York
| $38K | +$39.2K | +273 | New |
|
5
BlackRock
New York
| $26K | – | – | – |
|
|
TSS
6
Two Sigma Securities
New York
| $19K | +$20.3K | +141 | New |
|
|
OFS
7
Orrstown Financial Services
Harrisburg,
Pennsylvania
| $16K | – | – | – |
|
8
UBS Group
Zurich,
Switzerland
| $4K | +$3.16K | +22 | +367% |
|
|
9
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$58K | -357 | Closed |
|
|
10
Bank of New York Mellon
New York
| – | -$58K | -355 | Closed |
|
|
11
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$8K | -50 | Closed |
|
NURO Hedge Fund Activity: Q4 2017 in Review
8 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q4 2017, worth a combined $700K — up 36% from $515K a quarter earlier.
Fund positioning in NURO was balanced in Q4 2017: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, adding an estimated $155K. The largest seller was Bank of New York Mellon, exiting entirely with an estimated $58K sold.
- 8 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q4 2017, unchanged from Q3 2017.
- Funds reported $700K of NeuroMetrix, Inc. Common Stock stock for Q4 2017, up 36% quarter-over-quarter.
- 3 funds opened new NeuroMetrix, Inc. Common Stock positions in Q4 2017 and 3 closed out, a net change of 0 holders.
- The largest NeuroMetrix, Inc. Common Stock buyer in Q4 2017 was Sabby Management, an estimated $155K added.
- The largest NeuroMetrix, Inc. Common Stock seller in Q4 2017 was Bank of New York Mellon, an estimated $58K sold.
Based on aggregated 13F filings for Q4 2017.